SBIR/STTR Research Award

In-Space Manufacturing of Microfluidic Chips for Biological Research

Award identifier cff7b3622b4c2b84c48910695a86cf6c457621c7721fce088cd7ae91a7732241Awarding agency National Aeronautics and Space Administration

Award amount

$124,893

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Aeronautics and Space Administration
Branch
Not reported
Recipient company
TECHSHOT, INC.
Proposal award date
2019-08-19
Contract end date
2020-02-18
UEI
EYSXHJ3R7S53
Solicitation number
SBIR_19_P1
Topic code
H8

Research abstract

According to a recent Grand View Research report, the global 3D bioprinting market size was valued at USD 965.0 million in 2018 and is anticipated to grow at over 19.5% for the next 10 years. This includes all aspects of medical materials including metals, plastics, ceramics, biomaterials, cells, tissues and organ substitutes.nbsp; Advances in bioprinting are gaining importance and the tissues generated will soon become available for transplantation. In parallel, however, the use of human tissue analogs is becoming increasing valuable in drug discovery.nbsp; The tissue chip and micro-organ fields are growing at compound annual growth rate exceeding 34%.nbsp; These technologies and products are collectively known as organs-on-chips (OOCs).nbsp;nbsp;OOCs are microfluidic 3D cell culture devices that closely mimic the key physiological functions of body organs. The chips are not designed to mimic an entire organ but simulate the physiology of a single functional unit of an organ system. They have resulted from scientific advances in cell biology, microfabrication and microfluidics which allow the emulation of the human micro environment in vitro. This unique feature of OOCs is made possible by integrating biology with advanced engineering technologies such as bioprinting. Human OOCs are miniaturized versions of lungs, livers, kidneys, heart, brain, intestines and other vital human organs embedded in a chip.nbsp;The OOC and bioprinting fields are intrinsically linked and many groups, including Techshot researchers, are looking to leverage bioprinting OOCs to circumvent fundamental structural challenges faced in the race to bioprint large-scale organs for research and discovery.nbsp; To this end, Techshot has designed and built the first multi-head, ISS resident bioprinter with culture capability. The methods and system we are proposing here could print micro-organs in this facility to address the emerging OOC market and exploit the unique research potentials in microgravity.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

100 SBIR/STTR records share this UEI (1991–2021). Reported award amounts total $39,269,961. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: National Aeronautics and Space Administration, Department of Defense, Department of Health and Human Services, Department of Commerce, National Science Foundation

Agency intelligence

National Aeronautics and Space Administration

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.